Clinical Trial

Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury

Study acronym: PRECISE-AKI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Acute kidney injury (AKI) affects up to 20% of hospitalized Veterans and is strongly associated with morbidity and death. AKI is a diverse condition and timely and accurate diagnosis of the type of AKI is critical to begin appropriate therapies, especially those causes that require specific treatments beyond general supportive care. Yet, there are still significant gaps in the initial evaluation of AKI among hospitalized patients. Clinical decision support systems (CDSS) have shown promise to address these barriers, but most consist of simple alerting schemes and general care recommendations provided at a single point in time. The goal of this proposal is to develop and test the feasibility and usability of a rule-based and Artificial Intelligence-assisted precision CDSS tool (PRECISE-AKI) that can provide cognitive support to improve timely initial diagnostic evaluation of AKI.
Trial Details
NCT Number NCT07217808
Lead Sponsor VA Office of Research and Development
Collaborators: VA Tennessee Valley Health Care System, Vanderbilt University Medical Center
Conditions Acute Kidney Injury (AKI)
Enrollment 60 participants
Start Date 2028-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-16